Serial 90382533
Live / Registered — Registered (as of 04 Oct 2022)
What this means for you
Registered since 04 Oct 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90382533
- Registration number
- 6867217
- Mark type
- Design / logo
- Filed
- 15 Dec 2020
- Published for opposition
- 22 Jun 2021
- Registered
- 04 Oct 2022
- Attorney of record
- Cheryl L. Foytlin
Goods and services
- Class 005 — Pharmaceuticals: Human pharmaceuticals for the treatment of multiple myeloma
Owner
- JOHNSON & JOHNSON, New Brunswick, NJ, US
- JOHNSON & JOHNSON, New Brunswick, NJ, US
- JOHNSON & JOHNSON, New Brunswick, NJ, US
Prosecution history
- 04 Oct 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 04 Oct 2022 — REGISTERED-PRINCIPAL REGISTER
- 30 Aug 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 Aug 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 22 Aug 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Aug 2022 — USE AMENDMENT FILED
- 22 Aug 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Aug 2022 — TEAS STATEMENT OF USE RECEIVED
- 08 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Feb 2022 — SOU EXTENSION 1 GRANTED
- 04 Feb 2022 — SOU EXTENSION 1 FILED
- 04 Feb 2022 — SOU TEAS EXTENSION RECEIVED
- 24 Nov 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 24 Nov 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 24 Nov 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED